These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 21380990

  • 1. A randomized trial of micronized progesterone for the prevention of recurrent preterm birth.
    Glover MM, McKenna DS, Downing CM, Smith DB, Croom CS, Sonek JD.
    Am J Perinatol; 2011 May; 28(5):377-81. PubMed ID: 21380990
    [Abstract] [Full Text] [Related]

  • 2. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [Abstract] [Full Text] [Related]

  • 3. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone.
    Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A, PREDICT Group.
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):272-80. PubMed ID: 21739497
    [Abstract] [Full Text] [Related]

  • 4. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.
    Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A, PREDICT Group.
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):281-7. PubMed ID: 21739499
    [Abstract] [Full Text] [Related]

  • 5. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B, Karolinski A, Ocampo MC, Laterra C, Hösli I, Fernández D, Surbek D, Huespe M, Drack G, Bunader A, Rouillier S, López de Degani G, Seidenstein E, Prentl E, Antón J, Krähenmann F, Nowacki D, Poncelas M, Nassif JC, Papera R, Tuma C, Espoile R, Tiberio O, Breccia G, Messina A, Peker B, Schinner E, Mol BW, Kanterewicz L, Wainer V, Boulvain M, Othenin-Girard V, Bertolino MV, Irion O, 4P trial group.
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [Abstract] [Full Text] [Related]

  • 6. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
    Serra V, Perales A, Meseguer J, Parrilla JJ, Lara C, Bellver J, Grifol R, Alcover I, Sala M, Martínez-Escoriza JC, Pellicer A.
    BJOG; 2013 Jan; 120(1):50-7. PubMed ID: 22882759
    [Abstract] [Full Text] [Related]

  • 7. The effect of early administration of rectal progesterone in IVF/ICSI twin pregnancies on the preterm birth rate: a randomized trial.
    Aboulghar MM, El-Faissal Y, Kamel A, Mansour R, Serour G, Aboulghar M, Islam Y.
    BMC Pregnancy Childbirth; 2020 Jun 09; 20(1):351. PubMed ID: 32517660
    [Abstract] [Full Text] [Related]

  • 8. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct 09; 30(5):687-96. PubMed ID: 17899572
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR.
    Obstet Gynecol Clin North Am; 2011 Jun 09; 38(2):235-46, ix-x. PubMed ID: 21575799
    [Abstract] [Full Text] [Related]

  • 12. Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial.
    Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R, Conner M.
    Am J Obstet Gynecol; 2006 Mar 09; 194(3):617-23. PubMed ID: 16522388
    [Abstract] [Full Text] [Related]

  • 13. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study.
    Brizot ML, Hernandez W, Liao AW, Bittar RE, Francisco RPV, Krebs VLJ, Zugaib M.
    Am J Obstet Gynecol; 2015 Jul 09; 213(1):82.e1-82.e9. PubMed ID: 25731690
    [Abstract] [Full Text] [Related]

  • 14. Maintenance tocolysis with oral micronized progesterone for prevention of preterm birth after arrested preterm labor.
    Choudhary M, Suneja A, Vaid NB, Guleria K, Faridi MM.
    Int J Gynaecol Obstet; 2014 Jul 09; 126(1):60-3. PubMed ID: 24807871
    [Abstract] [Full Text] [Related]

  • 15. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study.
    Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Oliveto A, Kosten TR.
    Exp Clin Psychopharmacol; 2007 Oct 09; 15(5):453-60. PubMed ID: 17924779
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis.
    Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, Calder A, Mires G, Danielian P, Sturgiss S, MacLennan G, Tydeman G, Thornton S, Martin B, Thornton JG, Neilson JP, Norrie J.
    Lancet; 2009 Jun 13; 373(9680):2034-40. PubMed ID: 19523680
    [Abstract] [Full Text] [Related]

  • 18. Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial.
    van Os MA, van der Ven AJ, Kleinrouweler CE, Schuit E, Kazemier BM, Verhoeven CJ, de Miranda E, van Wassenaer-Leemhuis AG, Sikkema JM, Woiski MD, Bossuyt PM, Pajkrt E, de Groot CJ, Mol BW, Haak MC.
    Am J Perinatol; 2015 Aug 13; 32(10):993-1000. PubMed ID: 25738790
    [Abstract] [Full Text] [Related]

  • 19. The use of vaginal natural progesterone for prevention of preterm birth in IVF/ICSI pregnancies.
    Aboulghar MM, Aboulghar MA, Amin YM, Al-Inany HG, Mansour RT, Serour GI.
    Reprod Biomed Online; 2012 Aug 13; 25(2):133-8. PubMed ID: 22695310
    [Abstract] [Full Text] [Related]

  • 20. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth.
    Dodd JM, Ashwood P, Flenady V, Jenkins-Manning S, Cincotta R, Crowther CA.
    Aust N Z J Obstet Gynaecol; 2007 Apr 13; 47(2):106-9. PubMed ID: 17355298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.